Para-aminophenol sales will grow through 2036, led by pharmaceutical-grade para-aminophenol at 54.6% of the product segment in 2026. The market is projected to grow from USD 414.8 million in 2026 to USD 612.7 million by 2036, creating an incremental opportunity of USD 197.9 million between 2026 and 2036.